ID: ALA3577425

Max Phase: Preclinical

Molecular Formula: C26H46N4O4

Molecular Weight: 478.68

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC12CCC(C(NC(=O)[C@@H](CC3CCCCC3)NC(=O)N[C@@H](CCCCN)C(=O)O)C1)C2(C)C

Standard InChI:  InChI=1S/C26H46N4O4/c1-25(2)18-12-13-26(25,3)16-21(18)28-22(31)20(15-17-9-5-4-6-10-17)30-24(34)29-19(23(32)33)11-7-8-14-27/h17-21H,4-16,27H2,1-3H3,(H,28,31)(H,32,33)(H2,29,30,34)/t18?,19-,20+,21?,26?/m0/s1

Standard InChI Key:  MARJTHQRTDYWGB-HPIYHLJDSA-N

Associated Targets(Human)

Carboxypeptidase B 100 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Carboxypeptidase B2 isoform A 351 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 478.68Molecular Weight (Monoisotopic): 478.3519AlogP: 3.54#Rotatable Bonds: 11
Polar Surface Area: 133.55Molecular Species: ZWITTERIONHBA: 4HBD: 5
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.60CX Basic pKa: 10.21CX LogP: 0.75CX LogD: 0.75
Aromatic Rings: 0Heavy Atoms: 34QED Weighted: 0.29Np Likeness Score: 0.65

References

1. Halland N, Brönstrup M, Czech J, Czechtizky W, Evers A, Follmann M, Kohlmann M, Schiell M, Kurz M, Schreuder HA, Kallus C..  (2015)  Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin.,  58  (11): [PMID:25990761] [10.1021/jm501840b]

Source